Our Team

Our Team

Our Team

Kathryn Bieging-Rolett, Ph.D. came to HiberCell from Stanford University where she completed her postdoctoral training in cancer biology. Her work utilized functional genomics and mouse cancer models to understand the transcriptional programs that underlie tumor suppression by p53, a critical tumor suppressor in a variety of cancers. At Stanford, Kathryn was awarded multiple postdoctoral fellowships, including from the National Institutes of Health (NIH) and American Cancer Society, and co-authored numerous publications.

Kathryn received a BA in Biology from Macalester College and earned her Ph.D. at Northwestern University’s Feinberg School of Medicine.